Having discovered the palmitoylation motif of APLNR, we built a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the event of NCP, such as pain incidence, microglial activation, and inflammatory variable https://finnrkcrh.onzeblog.com/26909881/not-known-factual-statements-about-block-pain-receptors-with-proleviate